The FDA has been granted to Pemfexy™ (pemetrexed for injection; Eagle Pharmaceuticals), an alternative to Alimta® (Eli Lilly), for the treatment of non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma.
A pervading theme of this guideline was the importance of including genetic counselors in the interpretation and communication of germline and somatic testing results.
And, triplet and doublet drug regimens delay decline in quality of life in BRAF V600E metastatic CRC.
Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.
Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib
Trial unavailable at patients’ institution 55.6 percent of the time; 21.5 percent of patients ineligible
Metastasis-free survival is significantly longer among men with nonmetastatic, castration-resistant prostate cancer treated with darolutamide vs placebo, according to a phase 3 study published online February 14 in the New England Journal of Medicine.
Neoadjuvant administration of programmed cell death protein 1 (PD-1) blockade seems to enhance local and systemic antitumor immune response in glioblastoma, according to a study published online in Nature Medicine.
Autologous stem cell transplantation may be beneficial for some patients with nodal peripheral T-cell lymphoma in the first complete remission.
Want to read more?
Please login or register first to view this content.